{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T14:52:28Z","timestamp":1777906348794,"version":"3.51.4"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,1]]},"DOI":"10.7759\/cureus.16803","type":"journal-article","created":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T09:35:30Z","timestamp":1627810530000},"source":"Crossref","is-referenced-by-count":3,"title":["Acquired Hemophilia A in Peripartum Period: Diagnostic and Therapeutic Dilemma"],"prefix":"10.7759","author":[{"given":"Syed Hamza","family":"Bin Waqar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leen","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ather","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel M","family":"McFarlane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12138","article-title":"Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'H\u00e9mophilie Acquise) registry","volume":"19","author":"Borg JY","year":"2013","unstructured":"Borg JY, Guillet B, Le Cam-Duchez V, Goudemand J, L\u00e9vesque H. Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'H\u00e9mophilie Acquise) registry. Haemophilia. 2013, 19:564-70. 10.1111\/hae.12138","journal-title":"Haemophilia"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x","article-title":"Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"10","author":"Knoebl P","year":"2012","unstructured":"Knoebl P, Marco P, Baudo F, et al.. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012, 10:622-31. 10.1111\/j.1538-7836.2012.04654.x","journal-title":"J Thromb Haemost"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000014119","article-title":"Pregnancy-related acquired hemophilia A initially manifesting as pleural hemorrhage: a case report","volume":"98","author":"Qian L","year":"2019","unstructured":"Qian L, Ge H, Hu P, Zhu N, Chen J, Shen J, Zhang Y. Pregnancy-related acquired hemophilia A initially manifesting as pleural hemorrhage: a case report. Medicine (Baltimore). 2019, 98:e14119. 10.1097\/MD.0000000000014119","journal-title":"Medicine (Baltimore)"},{"key":"ref4","article-title":"A survey of 215 non-hemophilic patients with inhibitors to factor VIII","volume":"45","author":"Green D","year":"1981","unstructured":"Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to factor VIII. Thromb Haemost. 1981, 45:200-3.","journal-title":"Thromb Haemost"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.18388\/abp.2015_1056","article-title":"The factor VIII protein and its function","volume":"63","author":"Mazurkiewicz-Pisarek A","year":"2016","unstructured":"Mazurkiewicz-Pisarek A, P\u0142ucienniczak G, Ciach T, P\u0142ucienniczak A. The factor VIII protein and its function. Acta Biochim Pol. 2016, 63:11-6. 10.18388\/abp.2015_1056","journal-title":"Acta Biochim Pol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann MF","year":"1993","unstructured":"Bachmann MF, Rohrer UH, K\u00fcndig TM, B\u00fcrki K, Hengartner H, Zinkernagel RM. The influence of antigen organization on B cell responsiveness. Science. 1993, 262:1448-51. 10.1126\/science.8248784","journal-title":"Science"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-160432","article-title":"How we treat a hemophilia A patient with a factor VIII inhibitor","volume":"113","author":"Kempton CL","year":"2009","unstructured":"Kempton CL, White GC 2nd. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood. 2009, 113:11-7. 10.1182\/blood-2008-06-160432","journal-title":"Blood"},{"key":"ref8","article-title":"Immunochemical characterization of factor VIII inhibitors","volume":"150","author":"Hoyer LW","year":"1984","unstructured":"Hoyer LW, Gawryl MS, de la Fuente B. Immunochemical characterization of factor VIII inhibitors. Prog Clin Biol Res. 1984, 150:73-85.","journal-title":"Prog Clin Biol Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11817","article-title":"Postpartum-acquired hemophilia A presenting as hemoperitoneum: a case report","volume":"12","author":"Azam K","year":"2020","unstructured":"Azam K, Batool Z, Malik A, Chaudhry M, Abdullah M. Postpartum-acquired hemophilia A presenting as hemoperitoneum: a case report. Cureus. 2020, 12:e11817. 10.7759\/cureus.11817","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2017.12.016","article-title":"Newly diagnosed acquired hemophilia A manifesting as massive intracranial hemorrhage following a neurosurgical procedure","volume":"111","author":"Akamatsu Y","year":"2018","unstructured":"Akamatsu Y, Hayashi T, Yamamoto J, Karibe H, Kameyama M, Tominaga T. Newly diagnosed acquired hemophilia A manifesting as massive intracranial hemorrhage following a neurosurgical procedure. World Neurosurg. 2018, 111:175-80. 10.1016\/j.wneu.2017.12.016","journal-title":"World Neurosurg"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24777","article-title":"Acquired hemophilia A: updated review of evidence and treatment guidance","volume":"92","author":"Kruse-Jarres R","year":"2017","unstructured":"Kruse-Jarres R, Kempton CL, Baudo F, et al.. Acquired hemophilia A: updated review of evidence and treatment guidance. Am J Hematol. 2017, 92:695-705. 10.1002\/ajh.24777","journal-title":"Am J Hematol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12923","article-title":"Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A","volume":"166","author":"Batty P","year":"2014","unstructured":"Batty P, Platton S, Bowles L, Pasi KJ, Hart DP. Pre-analytical heat treatment and a FVIII ELISA improve Factor VIII antibody detection in acquired haemophilia A. Br J Haematol. 2014, 166:953-6. 10.1111\/bjh.12923","journal-title":"Br J Haematol"},{"key":"ref13","article-title":"The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability","volume":"73","author":"Verbruggen B","year":"1995","unstructured":"Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability. Thromb Haemost. 1995, 73:247-51.","journal-title":"Thromb Haemost"},{"key":"ref14","article-title":"Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients","volume":"31","author":"Hoyer LW","year":"1994","unstructured":"Hoyer LW, Scandella D. Factor VIII inhibitors: structure and function in autoantibody and hemophilia A patients. Semin Hematol. 1994, 31:1-5.","journal-title":"Semin Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12672","article-title":"Definitions in hemophilia: communication from the SSC of the ISTH","volume":"12","author":"Blanchette VS","year":"2014","unstructured":"Blanchette VS, Key NS, Ljung LR, Manco-Johnson MJ, van den Berg HM, Srivastava A. Definitions in hemophilia: communication from the SSC of the ISTH. J Thromb Haemost. 2014, 12:1935-9. 10.1111\/jth.12672","journal-title":"J Thromb Haemost"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408930","article-title":"Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry","volume":"120","author":"Baudo F","year":"2012","unstructured":"Baudo F, Collins P, Huth-K\u00fchne A, et al.. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012, 120:39-46. 10.1182\/blood-2012-02-408930","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-017988","article-title":"A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study","volume":"109","author":"Astermark J","year":"2007","unstructured":"Astermark J, Donfield SM, DiMichele DM, Gringeri A, Gilbert SA, Waters J, Berntorp E. A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood. 2007, 109:546-51. 10.1182\/blood-2006-04-017988","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-409185","article-title":"Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)","volume":"120","author":"Collins P","year":"2012","unstructured":"Collins P, Baudo F, Knoebl P, et al.. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012, 120:47-55. 10.1182\/blood-2012-02-409185","journal-title":"Blood"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26009","article-title":"Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study","volume":"96","author":"Schep SJ","year":"2021","unstructured":"Schep SJ, van Dijk WE, Beckers EA, et al.. Treatment of acquired hemophilia A, a balancing act: results from a 27-year Dutch cohort study. Am J Hematol. 2021, 96:51-9. 10.1002\/ajh.26009","journal-title":"Am J Hematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/66364-acquired-hemophilia-a-in-peripartum-period-diagnostic-and-therapeutic-dilemma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:40Z","timestamp":1707507220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/66364-acquired-hemophilia-a-in-peripartum-period-diagnostic-and-therapeutic-dilemma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,1]]},"references-count":19,"URL":"https:\/\/doi.org\/10.7759\/cureus.16803","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,1]]}}}